U.S. flag

An official website of the United States government

Format
Items per page
Sort by

Send to:

Choose Destination

Links from GEO Profiles

Items: 20

1.
Value/Rank Plot

BUB1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib

Annotation:
BUB1, BUB1 mitotic checkpoint serine/threonine kinase
Organism:
Homo sapiens
Reporter:
GPL570, 215509_s_at (ID_REF), GDS5826, 699 (Gene ID), AL137654
DataSet type:
Expression profiling by array, transformed count, 12 samples
2.
Value/Rank Plot

BUB1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib

Annotation:
BUB1, BUB1 mitotic checkpoint serine/threonine kinase
Organism:
Homo sapiens
Reporter:
GPL570, 209642_at (ID_REF), GDS5826, 699 (Gene ID), AF043294
DataSet type:
Expression profiling by array, transformed count, 12 samples
3.
Value/Rank Plot

BUB1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib

Annotation:
BUB1, BUB1 mitotic checkpoint serine/threonine kinase
Organism:
Homo sapiens
Reporter:
GPL570, 216277_at (ID_REF), GDS5826, 699 (Gene ID), AU156551
DataSet type:
Expression profiling by array, transformed count, 12 samples
4.
Value/Rank Plot

BUB1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib

Annotation:
BUB1, BUB1 mitotic checkpoint serine/threonine kinase
Organism:
Homo sapiens
Reporter:
GPL570, 216275_at (ID_REF), GDS5826, 699 (Gene ID)
DataSet type:
Expression profiling by array, transformed count, 12 samples
5.
Value/Rank Plot

BUB1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib

Annotation:
BUB1, BUB1 mitotic checkpoint serine/threonine kinase
Organism:
Homo sapiens
Reporter:
GPL570, 215508_at (ID_REF), GDS5826, 699 (Gene ID), AL137654
DataSet type:
Expression profiling by array, transformed count, 12 samples
6.
Value/Rank Plot

RGPD2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib

Annotation:
RGPD2, RANBP2-like and GRIP domain containing 2 (multiple annotations exist)
Organism:
Homo sapiens
Reporter:
GPL570, 242712_x_at (ID_REF), GDS5826, 5903 (Gene ID), 84220 (Gene ID), 285190 (Gene ID), 400966 (Gene ID), 653489 (Gene ID), 727851 (Gene ID), 729540 (Gene ID), 729857 (Gene ID)
DataSet type:
Expression profiling by array, transformed count, 12 samples
7.
Value/Rank Plot

RGPD6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib

Annotation:
RGPD6, RANBP2-like and GRIP domain containing 6 (multiple annotations exist)
Organism:
Homo sapiens
Reporter:
GPL570, 212842_x_at (ID_REF), GDS5826, 84220 (Gene ID), 285190 (Gene ID), 653489 (Gene ID), 727851 (Gene ID), 729540 (Gene ID), AL043571
DataSet type:
Expression profiling by array, transformed count, 12 samples
8.
Value/Rank Plot

RGPD6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib

Annotation:
RGPD6, RANBP2-like and GRIP domain containing 6 (multiple annotations exist)
Organism:
Homo sapiens
Reporter:
GPL570, 211324_s_at (ID_REF), GDS5826, 84220 (Gene ID), 285190 (Gene ID), 653489 (Gene ID), 727851 (Gene ID), 729540 (Gene ID), AL136868
DataSet type:
Expression profiling by array, transformed count, 12 samples
9.
Value/Rank Plot

RGPD6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib

Annotation:
RGPD6, RANBP2-like and GRIP domain containing 6 (multiple annotations exist)
Organism:
Homo sapiens
Reporter:
GPL570, 210676_x_at (ID_REF), GDS5826, 84220 (Gene ID), 285190 (Gene ID), 653489 (Gene ID), 727851 (Gene ID), 729540 (Gene ID), U64675
DataSet type:
Expression profiling by array, transformed count, 12 samples
10.
Value/Rank Plot

LIMS4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib

Annotation:
LIMS4, LIM zinc finger domain containing 4 (multiple annotations exist)
Organism:
Homo sapiens
Reporter:
GPL570, 223800_s_at (ID_REF), GDS5826, 96626 (Gene ID), 100288695 (Gene ID), AF288404
DataSet type:
Expression profiling by array, transformed count, 12 samples
11.
Value/Rank Plot

LIMS4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib

Annotation:
LIMS4, LIM zinc finger domain containing 4 (multiple annotations exist)
Organism:
Homo sapiens
Reporter:
GPL570, 207198_s_at (ID_REF), GDS5826, 3987 (Gene ID), 100288695 (Gene ID), NM_004987
DataSet type:
Expression profiling by array, transformed count, 12 samples
12.
Value/Rank Plot

LIMS4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib

Annotation:
LIMS4, LIM zinc finger domain containing 4 (multiple annotations exist)
Organism:
Homo sapiens
Reporter:
GPL570, 212687_at (ID_REF), GDS5826, 3987 (Gene ID), 96626 (Gene ID), 100288695 (Gene ID), AL110164
DataSet type:
Expression profiling by array, transformed count, 12 samples
13.
Value/Rank Plot

LOC100507334 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib

Annotation:
LOC100507334, two pore channel 3 pseudogene (multiple annotations exist)
Organism:
Homo sapiens
Reporter:
GPL570, 229096_at (ID_REF), GDS5826, 440895 (Gene ID), 100271835 (Gene ID), 100288570 (Gene ID), 100507334 (Gene ID), AI797263
DataSet type:
Expression profiling by array, transformed count, 12 samples
14.
Value/Rank Plot

LOC100507334 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib

Annotation:
LOC100507334, two pore channel 3 pseudogene (multiple annotations exist)
Organism:
Homo sapiens
Reporter:
GPL570, 229095_s_at (ID_REF), GDS5826, 440895 (Gene ID), 100271835 (Gene ID), 100288570 (Gene ID), 100507334 (Gene ID), AI797263
DataSet type:
Expression profiling by array, transformed count, 12 samples
15.
Value/Rank Plot

LOC100288570 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib

Annotation:
LOC100288570, glycosylphosphatidylinositol anchor attachment protein 1 homolog (yeast) pseudogene
Organism:
Homo sapiens
Reporter:
GPL570, 215247_at (ID_REF), GDS5826, 100288570 (Gene ID), AI561253
DataSet type:
Expression profiling by array, transformed count, 12 samples
16.
Value/Rank Plot

ACOXL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib

Annotation:
ACOXL, acyl-CoA oxidase-like
Organism:
Homo sapiens
Reporter:
GPL570, 240189_at (ID_REF), GDS5826, 55289 (Gene ID), BF064226
DataSet type:
Expression profiling by array, transformed count, 12 samples
17.
Value/Rank Plot

ACOXL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib

Annotation:
ACOXL, acyl-CoA oxidase-like
Organism:
Homo sapiens
Reporter:
GPL570, 220845_at (ID_REF), GDS5826, 55289 (Gene ID)
DataSet type:
Expression profiling by array, transformed count, 12 samples
18.
Value/Rank Plot

BCL2L11 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib

Annotation:
BCL2L11, BCL2 like 11
Organism:
Homo sapiens
Reporter:
GPL570, 222343_at (ID_REF), GDS5826, 10018 (Gene ID), AA629050
DataSet type:
Expression profiling by array, transformed count, 12 samples
19.
Value/Rank Plot

BCL2L11 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib

Annotation:
BCL2L11, BCL2 like 11
Organism:
Homo sapiens
Reporter:
GPL570, 1558143_a_at (ID_REF), GDS5826, 10018 (Gene ID), AK027160
DataSet type:
Expression profiling by array, transformed count, 12 samples
20.
Value/Rank Plot

BCL2L11 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib

Annotation:
BCL2L11, BCL2 like 11
Organism:
Homo sapiens
Reporter:
GPL570, 1553096_s_at (ID_REF), GDS5826, 10018 (Gene ID), NM_138627
DataSet type:
Expression profiling by array, transformed count, 12 samples
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Profile data

Download profile data help

Find related data

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center